2004

1. Stokłosa T., Słupianek A., Datta M., Nieborowska-Skorska M., Nowicki MO, Koptyra M. Skórski T. BCR/ABL recruits p53 tumor suppressor protein to induce drug resistance. Cell Cycle 2004, 3 (11), e93-e102

2. Nowicki MO., Faliński R., Koptyra M., Słupianek A., Stokłosa T., Gloc E., Nieborowska-Skorska M., Błasiak J., Skórski T. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species - dependent DNA double-strand breaks. Blood 2004, 104(12), 3746-3753;

3. Issat T, Nowis D, Jakóbisiak M, Gołąb J. Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells. Oncol Rep. 2004;12(6):1371-5.

4. Mrówka P, Gołąb J. Receptor NKG2D i jego ligandy. Post Biol Kom 2004; 31: 71-80.

5. Gołąb J, Bauer TM, Daniel V, Naujokat C. Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases. Clin Chim Acta. 2004 Feb;340(1-2):27-40.
6. Młynarczuk I, Mróz P, Hoser G, Nowis D, Biały LP, Ziemba H, Grzela T, Feleszko W, Malejczyk J, Wójcik C, Jakóbisiak M, Gołąb J. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res. 2004; 28: 53-61.

7. Kopeć M, Strusińska K, Legat M, Makowski M, Jakóbisiak M, Gołąb J. Potentiated antitumor effects of a combination therapy with a farnesyltransferase inhibitor L-744,832 and butyrate in vitro. Oncol Rep. 2004; 11: 1127-1131.

8. Łazarczyk M, Grzela T, Niderla J, Łazarczyk MA, Milewski L, Dziunycz P, Skopiński P, Gołąb J. Differential influence of pentoxifylline on murine colon adenocarcinoma- and melanoma-derived metastatic tumor development in lungs. Oncol Rep. 2004; 11: 1121-1125.

9. Kozar K, Kamiński R, Legat M, Kopeć M, Nowis D, Skierski JS, Koronkiewicz M, Jakóbisiak M, Gołąb J. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin. Int J Oncol. 2004; 24: 1149-1157.

10. Stoklosa T, Golab J, Wojcik C, Wlodarski P, Jalili A, Januszko P, Giermasz A, Wilczynski GM, Pleban E, Marczak M, Wilk S, Jakobisiak M. Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor. Apoptosis. 2004 ;9: 193-204.
11. Lasek W, Basak G, Switaj T, Jakubowska AB, Wysocki PJ, Mackiewicz A, Drela N, Jalili A, Kaminski R, Kozar K, Jakobisiak M. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice. Cancer Immunol Immunother. 2004; 53: 363-372.

12. Świtaj T, Jalili A, Jakubowska AB, Drela N, Stoksik M, Nowis D, Basak G, Gołąb J, Wysocki PJ, Mackiewicz A, Sasor A, Socha-Urbanek K, Jakóbisiak M, Lasek W. CpG immunostimulatory oligodeoxynucleotide (ODN) 1826 enhances antitumor effec of IL-12 gene-modified vaccine in a melanoma model in mice. Clin Cancer Res 2004 Jun 15;10(12 Pt 1):4165-75.

13. Jalili A, Makowski M, Świtaj T, Nowis N, Wilczyński GM, Wilczek E, Chorąży-Massalska M, Radzikowska A, Maśliński W, Biały Ł, Sieńko J, Sieroń A, Adamek M, Basak G, Mróz P, Krasnodębski IW, Jakóbisiak M, Gołąb J. Effective photoimmunotherapy of murine colon carcinoma induced by the combinationn of photodynamic therapy and dendritic cells. Clin Cancer Res 2004 Jul 1;10(13):4498-508.

14. Kamiński R, Kozar K, Niderla J, Grzela T, Wilczyński G, Skierski JS, Koronkiewicz M, Jakóbisiak M, Gołąb J. Demethylating agent 5-aza-2'-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo. Oncol Rep 2004 (in press)